Apr 22 |
S&P 500 Rises Over 1%; Zions Bancorp Shares Gain After Q1 Earnings
|
Apr 22 |
Why Riot Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
|
Apr 19 |
Vaxxinity Issues Shareholder Letter
|
Apr 19 |
Vaxxinity announces intention to voluntarily delist and deregister Class A common stock
|
Apr 19 |
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
|
Mar 28 |
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
|
Mar 27 |
Vaxxinity GAAP EPS of -$0.09
|
Mar 27 |
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates
|
Mar 7 |
Vaxxinity gains after early-stage data for Parkinson’s disease drug
|
Mar 7 |
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024
|